Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on June 7, 2026

Jun. 7, 2026

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Indeterminate GlobeNewswire

Jun. 7, 2026

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

Indeterminate GlobeNewswire

Jun. 7, 2026

Australian Retirees Seek Reliable Monthly Income From Global Private Credit as Inflation Bites and TermPlus Targets Up To 8.50%* Per Annum

Indeterminate GlobeNewswire

Jun. 7, 2026

Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Indeterminate GlobeNewswire

Jun. 7, 2026

Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management

Indeterminate GlobeNewswire

Jun. 7, 2026

SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation

Indeterminate GlobeNewswire

Jun. 7, 2026

NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand

Indeterminate GlobeNewswire

Jun. 7, 2026

NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories

Indeterminate GlobeNewswire

Jun. 7, 2026

Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes

Indeterminate GlobeNewswire

Jun. 7, 2026

Canadian Employers Invited to Create 10,000 New Opportunities Through National Inclusive Hiring Campaign

Indeterminate GlobeNewswire

Jun. 7, 2026

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

Indeterminate GlobeNewswire

Jun. 7, 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Indeterminate GlobeNewswire

Jun. 7, 2026

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis

Indeterminate GlobeNewswire

Jun. 7, 2026

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

Indeterminate GlobeNewswire

Jun. 7, 2026

Dietz & Watson Expands Its Premium Deli Chicken Lineup with Launch of Heritage Roast and Cantina Chicken Breast at IDDBA 2026

Indeterminate GlobeNewswire

Jun. 7, 2026

MemeToro Price Prediction: $1 Talk Returns as Presale Buyers Bet on MemeToro AI Agent Solutions

Indeterminate GlobeNewswire

Jun. 7, 2026

See What the Market Is Talking About — Before It Moves

Indeterminate GlobeNewswire

Jun. 7, 2026

Unlocking the Americas: Air Canada and Abra Group Sign Memorandum to Expand Travel and Connectivity between Canada, Latin America and Beyond

Indeterminate GlobeNewswire

Jun. 7, 2026

Ouvrir l’accès aux Amériques : Air Canada et Abra Group signent un protocole d’entente visant à étendre les voyages et la connectivité entre le Canada, l’Amérique latine et au-delà

Indeterminate GlobeNewswire

Jun. 7, 2026

Astrall Dynamics Unveils Integrated Quadruped Firefighting Robot Hypertron-T01 at INTERSCHUTZ 2026

Indeterminate GlobeNewswire